Transcranial Magnetic Stimulation Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Transcranial Magnetic Stimulation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Personalized iTBS in Real-World Clinical Settings for Schizophrenia

SchizophreniaTranscranial Magnetic Stimulation
Anhui Medical University40 enrolled2 locationsNCT07176468
Recruiting
Not Applicable

Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression

Transcranial Magnetic StimulationTreatment Resistant Depression (TRD)Accelerated Protocol+3 more
Ataturk University60 enrolled1 locationNCT07264452
Recruiting
Not Applicable

Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)

Alzheimer DiseaseTranscranial Magnetic StimulationCerebellum
Xijing Hospital100 enrolled4 locationsNCT06669182
Recruiting
Not Applicable

Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial

Alzheimer's DiseaseTranscranial Magnetic StimulationIndividualized Navigation
Anhui Medical University40 enrolled1 locationNCT07138677
Recruiting
Phase 1Phase 2

Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels

Depression - Major Depressive DisorderTranscranial Magnetic StimulationPlacebo
Universidad de Guanajuato40 enrolled1 locationNCT06667180
Recruiting
Not Applicable

Intermittent Theta Burst Stimulation in Fibromyalgia Syndrome

PainFibromyalgiaTranscranial Magnetic Stimulation Repetitive
Izmir Katip Celebi University30 enrolled1 locationNCT06746922
Recruiting
Not Applicable

Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia

SchizophreniaTranscranial Magnetic StimulationHallucinations, Verbal Auditory
Dominique JANUEL30 enrolled1 locationNCT06599372
Recruiting
Not Applicable

An Open-label Study on the Clinical Efficacy of rTMS Intervention in PD

Parkinson DiseaseTranscranial Magnetic StimulationSupplementary Motor Area
Anhui Medical University20 enrolled1 locationNCT06542991